On May 4, 2021, the American Society of Nephrology (ASN) provided input to the Agency for Healthcare Research and Quality (AHRQ) in response to a Request for Information (RFI) on the use of clinical algorithms that may introduce racial/ethnic bias.
Reaffirming that race is a social, not a biological, construct, ASN remains committed to ensuring that racial and ethnic biases do not affect the diagnosis and treatment of kidney diseases. As stated in a letter to ASN membership in March 2021, ASN asserts that 1) race modifiers should not be included in equations to estimate kidney function and 2) current race-based equations should be replaced by a suitable approach that is accurate, inclusive, and standardized in every
laboratory in the United States. Any such approach must not differentially introduce bias, inaccuracy, or inequalities.